Sustained Progress: Does Mounjaro Stop Working After a Year?

Last reviewed: July 15, 2026

Last updated: July 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide delivers impressive weight loss results in clinical trials, with patients losing an average of 20–22% of body weight over 68 weeks. However, some people report that their progress slows or stops after 12 months of continuous use. Understanding why this happens—and what to do about it—helps you maintain momentum toward your health goals.

Why Tirzepatide's Effectiveness May Plateau After One Year

The human body adapts to medications over time through a process called tolerance. With tirzepatide, your GLP-1 and GIP receptors gradually become less responsive to the same dose as your system recalibrates. This doesn't mean the drug has stopped working; it means your body has acclimated to the current dose level. Weight plateaus are normal and expected in long-term weight management therapy, not a sign of treatment failure.

Additionally, your baseline metabolic rate and hunger regulation have shifted. As you lose weight, your body requires fewer calories to maintain its new size. Your appetite-suppressing hormones (GLP-1 and GIP) must work harder to override the metabolic signals telling your body to eat more and preserve its previous weight. This biological pushback is your body's natural attempt to defend against further weight loss.

Lifestyle creep also plays a role. Small increases in portion sizes, snacking frequency, or reduced physical activity—almost imperceptible over months—can offset tirzepatide's appetite control benefits. Reviewing food logs and meal patterns after one year often reveals subtle dietary shifts.

Dose Optimization: The Standard Response to Tirzepatide Resistance

When tirzepatide's effects plateau, the first clinical response is dose escalation. Most patients start at a lower dose and titrate upward every four weeks until reaching an effective maintenance dose. If your initial dose no longer produces the same appetite suppression or weight loss, your prescriber may increase your dose to re-engage your GLP-1 and GIP receptors more effectively. Tirzepatide doses range from 2.5 mg up to 15 mg weekly, offering substantial room for adjustment.

Importantly, your price remains the same whether you use the starting dose or the maximum dose. PlexusDx's compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) regardless of your weekly dose—your medication cost is flat, not escalating with dose increases. This pricing structure ensures that dose optimization doesn't create financial barriers to maintaining your treatment effectiveness.

Your provider will monitor your response to each dose adjustment and may recommend holding at a particular dose if side effects outweigh benefits, or continuing to increase if you tolerate it well and continue losing weight.

Genetic Predisposition and Long-Term Tirzepatide Response

Not everyone responds to tirzepatide identically. Genetic variants in your GLP-1 receptor (GLP1R rs6923761), GIP receptor (GIPR rs1800437), and metabolic genes like FTO and MC4R influence how strongly you respond to tirzepatide and how quickly tolerance develops. Some people are genetically primed for robust, sustained weight loss, while others may experience faster tolerance or need higher doses to achieve the same effect.

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Patients with favorable genetic profiles for GLP-1R sensitivity often maintain strong appetite suppression and steady weight loss even at stable doses. Those with variants associated with faster receptor adaptation may benefit from earlier dose escalation or combination therapy (such as GLP-Squared, which pairs semaglutide and tirzepatide).

Strategies to Sustain Weight Loss Beyond the One-Year Mark

Beyond dose adjustments, several evidence-based strategies help maintain tirzepatide's benefits. First, reassess your nutrition: return to protein-forward meals, controlled portion sizes, and consistent meal timing. Tirzepatide is a tool that reduces hunger and improves satiety, but it works best when paired with intentional eating patterns. Second, increase physical activity or resistance training, which accelerates weight loss and boosts metabolism independent of medication. Third, ensure consistent sleep and stress management, as poor sleep and chronic stress trigger hunger hormones that can overcome tirzepatide's appetite suppression.

For some patients, cycling off tirzepatide briefly (under medical supervision) can reset receptor sensitivity. Others benefit from switching to a different GLP-1 or dual agonist to reactivate plateaued progress. PlexusDx also offers compounded semaglutide and the GLP-Squared dual compound, allowing your provider to personalize your therapy if tirzepatide alone loses effectiveness. A medication switch may restore weight loss momentum without requiring a dose increase on your original therapy.

When to Expect Tirzepatide Tolerance and How to Plan Ahead

Most patients reach their initial goal weight or a stable plateau between 6 and 18 months of tirzepatide therapy. Some maintain strong satiety indefinitely at a fixed dose, while others require incremental dose increases every 3–6 months to sustain the same level of appetite control. Discussing this variability with your prescriber during your first consultation helps set realistic expectations and informs your long-term cost and treatment strategy.

Working with PlexusDx means your prescriber has access to a full range of compounded options—from microdose protocols ($129/mo) to dual-agonist combinations—allowing flexible adjustments as your needs change. No membership fees, no insurance requirements, and HSA/FSA eligibility mean you can adjust your medication and dosing without unexpected cost shocks. Requesting the Precision Peptide Genetic Test within your first month gives your team a personalized roadmap for anticipating and managing tolerance risk before it affects your progress.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it normal for tirzepatide to stop working after 12 months?

Yes, many patients experience a plateau in weight loss or appetite suppression around the one-year mark due to receptor tolerance and metabolic adaptation. This is a recognized phenomenon in GLP-1 therapy, not a sign of failure. Dose escalation, lifestyle adjustments, or medication switches can restore progress.

What does the clinical evidence say about tirzepatide's long-term effectiveness?

The SURMOUNT trials followed tirzepatide patients for up to 2 years and showed sustained weight loss with dose adjustments. Most patients who continued treatment and optimized their dose maintained or continued losing weight beyond the first year.

How much does it cost to increase my tirzepatide dose with PlexusDx?

PlexusDx's compounded tirzepatide injection costs a flat $289/mo (or $249/mo on the 6-month plan) regardless of your dose level—whether you're taking 2.5 mg or 15 mg weekly. Your dose may go up, but your price won't, ensuring dose optimization remains affordable.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence your responsiveness to tirzepatide and the speed of tolerance development. This $99 test, taken after your first month, helps your provider anticipate your long-term response pattern and adjust your strategy proactively.

What can I do if tirzepatide stops working after one year?

First, work with your prescriber to increase your dose (PlexusDx's pricing stays flat with dose changes). Second, review your nutrition and exercise habits for lifestyle drift. Third, consider genetic testing to understand your individual response profile. If needed, your provider can switch you to a different medication, such as compounded semaglutide or the GLP-Squared dual compound.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.